190.00
-2.00 (-1.04%)
| Previous Close | 192.00 |
| Open | 194.40 |
| Volume | 30,313 |
| Avg. Volume (3M) | 36,816 |
| Market Cap | 201,996,592 |
| Price / Sales | 7.57 |
| Price / Book | 1.43 |
| 52 Weeks Range | |
| Earnings Date | 7 May 2025 |
| Profit Margin | -106.29% |
| Operating Margin (TTM) | -148.41% |
| Diluted EPS (TTM) | -0.290 |
| Quarterly Revenue Growth (YOY) | -44.50% |
| Total Debt/Equity (MRQ) | 8.74% |
| Current Ratio (MRQ) | 10.88 |
| Operating Cash Flow (TTM) | -27.61 M |
| Levered Free Cash Flow (TTM) | -13.72 M |
| Return on Assets (TTM) | -12.60% |
| Return on Equity (TTM) | -18.73% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (GB) | Mixed | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | MAXCYTE INC COM STK USD0.01 (DI | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 3.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 1.38 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| MAXCYTE INC COM STK USD0.01 (DI | 202 M | - | - | 1.43 |
| 0K5E | 765 M | 4.01% | 7.06 | - |
| CREO MEDICAL GROUP PLC ORD GBP0 | 44 M | - | - | 1.57 |
| INTELLIGENT ULTRASOUND GROUP PL | 36 M | - | - | 7.29 |
| NOVACYT S.A. EUR1/15TH (CDI) | 34 M | - | - | 0.710 |
| INSPIRATION HEALTHCARE GROUP PL | 15 M | - | - | 0.550 |
|
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 1.56% |
| % Held by Institutions | 74.58% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |